EyeGene Inc.

KOSDAQ:A185490 株式レポート

時価総額：₩77.3b

EyeGene マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Won-Il Yoo

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間24.4yrs
CEOの所有権4.8%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

更新なし

Recent updates

Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Jul 26
Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

Mar 29
Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Feb 01
EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

Dec 07
Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

CEO（最高経営責任者

Won-Il Yoo

24.4yrs

在職期間

Mr. Won-Il Yoo has been Chief Executive Officer of EyeGene, Inc. since June 2000. Mr. Yoo has directed EyeGene's initial financing, set-up, recruiting, R&D and business development. He has over 12 years re...